The extension buys time but does not fix the underlying cash burn and going-concern risk. Monitor for any reverse stock split or reverse ADS ratio adjustment as the April 2027 deadline approaches, and watch the next 20-F for any improvement in cash position or operational milestones.
Price Chart
Executive Summary
RedHill Biopharma received a 180-day extension from Nasdaq, until April 5, 2027, to regain compliance with the $1.00 minimum bid price requirement for its ADSs. The company meets all other listing requirements and the extension provides temporary relief from delisting risk, but the underlying financial distress and going-concern uncertainty highlighted in the prior 20-F filing remain unresolved.
Key Facts
- Nasdaq granted RedHill an additional 180 calendar days, until April 5, 2027, to regain compliance with the $1.00 minimum bid price rule.
- The company received the initial deficiency notice on April 8, 2026, and the original compliance period expired on October 5, 2026.
- RedHill meets all other Nasdaq continued listing requirements except the minimum bid price.
- Compliance can be achieved if the ADS closing bid price is at least $1.00 for 10 consecutive business days before the new deadline.
- The extension has no immediate effect on the listing or trading of the ADSs under the symbol 'RDHL'.
Financial Impact
No financial figures provided in the filing. The extension avoids immediate delisting but does not resolve the company's cash position or going-concern issues.
Risk Factors
- If the ADS price fails to stay above $1.00 for 10 consecutive days by April 5, 2027, delisting remains a real risk.
- The company's going-concern uncertainty and limited cash ($4.1M as of the last 20-F) persist despite the listing extension.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001178913-26-004732 |
| Document: 0001178913-26-004732-index-headers.html | 0001178913-26-004732 |
| Document: 0001178913-26-004732-index.html | 0001178913-26-004732 |
| Document: 0001178913-26-004732.txt | 0001178913-26-004732 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 6-K | $0.4550 | awaiting T+60 | — | $0.4230 (−7.03%) |
Oct 19, 2026 7d ago | 6-K | $0.5012 | awaiting T+60 | — | $0.4230 (−15.60%) |
Oct 19, 2026 7d ago | Press Release | $0.5012 | awaiting T+60 | — | $0.4230 (−15.60%) |
Oct 13, 2026 12d ago | 6-K | $0.4862 | awaiting T+60 | — | $0.4230 (+13.00%) |
Oct 13, 2026 12d ago | 424B5 | $0.4862 | awaiting T+60 | — | $0.4230 (+13.00%) |
Oct 7, 2026 19d ago | 6-K | $0.4740 | awaiting T+60 | — | $0.4230 (−10.76%) |
Sep 1, 2026 7w ago | 6-K | $0.8700 | awaiting T+60 | — | $0.4230 (−51.38%) |
Aug 31, 2026 8w ago | 6-K | $0.9000 | awaiting T+60 | — | $0.4230 (−53.00%) |
Aug 7, 2026 11w ago | 6-K | $0.6050 | awaiting T+60 | — | $0.4230 (−30.08%) |
Aug 6, 2026 11w ago | 6-K | $0.5810 | awaiting T+60 | — | $0.4230 (−27.19%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers